(Reuters) – Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
(Reporting by Leroy Leo in Bengaluru; Editing by Alan Barona)
(Reuters) – Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.
(Reporting by Leroy Leo in Bengaluru; Editing by Alan Barona)

Comments